Community curated by people like you

Cambridge stories

Nov 13, 2026

AstraZeneca cuts 600 US sales jobs in respiratory and immunology

AstraZeneca has eliminated approximately 600 positions from its US respiratory and immunology commercial teams as part of a three-year cost-savings initiative.

Nov 13, 2026·2 sources

00

Top claims

▪GSK Plc plans to relocate its research and development headquarters to Cambridge, United Kingdom, near AstraZeneca's global headquarters
▪AstraZeneca pledged to invest $50 billion in the United States to expand manufacturing operations and generate tens of thousands of jobs
▪Rival drugmaker GSK Plc is reducing costs to fund pipeline development before patent protection expires on an HIV drug before 2030

Topics

Asthma Pharmaceutical patents Pharmaceutical Industry COPD Corporate strategy Corporate restructuring Corporate layoffs

Related entities